首页> 美国卫生研究院文献>Acta Naturae >Silencing of Her2 CCNB1 and PKC Genes by siRNA Results in ProlongedRetardation of Neuroblastoma Cell Division
【2h】

Silencing of Her2 CCNB1 and PKC Genes by siRNA Results in ProlongedRetardation of Neuroblastoma Cell Division

机译:siRNA沉默Her2CCNB1和PKC基因会延长时间延缓神经母细胞瘤细胞分裂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Deregulation of the expression of the genes that are involved in the control of the cell cycle impairs cellular differentiation and leads to cell death. This process can result in uncontrollable cell proliferation and, subsequently, cancer development. In this study, we examined the effect of the silencing of cancer-related genes by small interfering RNAs (siRNA) targeted at mRNAof Her2, cyclin B1 (CCNB1), and protein kinase C(PKC) on the proliferation of human cancer cells of different origins. Maximum silencing ofCCNB1,Her2(in KB-3-1, SK-N-MC, MCF-7 cells), andPKC(in MCF-7 cells) was achieved 72 h after transfection of the corresponding siRNAs, and 12 days after the transfection, the initial levels of the target mRNAs were fully recovered. Silencing ofHer2,CCNB1,andPKCdifferently effected the proliferation of the cell lines under study. The most pronounced antiproliferative action of the investigated siRNAs was observed in neuroblastoma SK-N-MC cells (3 – 10-fold reduction in the proliferation rate) even after the recovery of the initial levels of expressionofthe Her2,CCNB1,andPKС genes. The obtained data indicatethat theCCNB1 andPKCgenes can be used astargets in the development of drugs for neuroblastoma treatment.
机译:参与细胞周期控制的基因表达失调会损害细胞分化并导致细胞死亡。这个过程可能导致无法控制的细胞增殖,进而导致癌症发展。在这项研究中,我们研究了针对Her2,cyclin B1(CCNB1)和蛋白激酶C(PKC)的mRNA的小干扰RNA(siRNA)对癌症相关基因的沉默对不同人类癌细胞增殖的影响起源。转染相应siRNA后72小时和转染后12天,CCNB1,Her2(在KB-3-1,SK-N-MC,MCF-7细胞中)和PKC(在MCF-7细胞中)达到最大沉默,目标mRNA的初始水平已完全恢复。沉默Her2,CCNB1和PKC分别影响所研究细胞系的增殖。即使在初始表达水平恢复后,在成神经细胞瘤SK-N-MC细胞中观察到所研究的siRNA的最明显的抗增殖作用(增殖率降低了3-10倍)。Her2,CCNB1,和PKС基因。获得的数据表明CCNB1和PKC基因可以用作靶向治疗神经母细胞瘤的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号